nsc 338720 has been researched along with Central Nervous System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowling, K; Chen, TL; Donehower, RC; Grochow, LB; Hartman, NR; O'Reilly, S; Rowinsky, EK; Struck, RF | 1 |
1 trial(s) available for nsc 338720 and Central Nervous System Diseases
| Article | Year |
|---|---|
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Central Nervous System Diseases; Female; Humans; Male; Middle Aged; Neoplasms; Picolines; Platelet Count | 1997 |